News

The approval allows the DMD gene therapy to be sold in Japan for up to seven years, but more trials will be needed for full ...
Aging with FSHD brings many challenges, columnist Robin Stemple says, but he works hard to maintain an attitude of gratitude.
Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...
The PJ Nicholoff Protocol is intended to help prevent adrenal insufficiency, a complication of corticosteroid therapy in ...
Solve FSH invested $3 million to advance Armatus Bio's microRNA-based therapy ARM-201 as a treatment for FSHD, a type of ...
On April 25, the Muscular Dystrophy Association (Singapore), or MDAS, celebrated its 25th anniversary with a spectacular gala at Marina Bay Sands, an iconic hotel and convention center here in ...
The U.S. Food and Drug Administration gave Capricor Therapeutics' application on deramiocel priority review, with a decision ...